Olmetec Tablet 20mg Singapore - English - HSA (Health Sciences Authority)

olmetec tablet 20mg

pfizer private limited - olmesartan medoxomil - tablet, film coated - 20mg - olmesartan medoxomil 20mg

Olmetec Tablet 40mg Singapore - English - HSA (Health Sciences Authority)

olmetec tablet 40mg

pfizer private limited - olmesartan medoxomil - tablet, film coated - 40mg - olmesartan medoxomil 40mg

AGGRASTAT CONCENTRATE FOR INFUSION 0.25 mgml Singapore - English - HSA (Health Sciences Authority)

aggrastat concentrate for infusion 0.25 mgml

dch auriga singapore - tirofiban hydrochloride monohydrate - injection - 0.281 mg/ml - tirofiban hydrochloride monohydrate 0.281 mg/ml

Interpretive software IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

interpretive software ivds

genome investigation pty ltd - ct910 - interpretive software ivds - the agendia-secured data analysis pipeline tool (adapt) takes gene expression profiling data (.fastq file) from the mammaprint breast cancer recurrence risk and blueprint molecular subtyping kit (see artg 356739) to generate both a breast cancer distant recurrence risk and a molecular subtype (luminal, basal or her2) of the formalin-fixed, paraffin-embedded (ffpe) breast cancer tissue.

Acquired genetic alteration IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

acquired genetic alteration ivds

genome investigation pty ltd - ct929 - acquired genetic alteration ivds - the mammaprint breast cancer recurrence risk and blueprint molecular subtyping ngs kit is an in vitro diagnostic which generates data (.fastq file) from gene expression profiling of breast cancer tissue performed by next generation sequencing. this data is used to generate both a breast cancer distant recurrence risk and a molecular subtype (luminal, basal or her2) via a second step using the agendia-secured data analysis pipeline tool (adapt) (see artg 356740). the assay measures the gene expression profile on a next generation sequencer using rna extracted from formalin-fixed, paraffin-embedded (ffpe) breast cancer tissue.

Alternating-pressure bed mattress overlay system Australia - English - Department of Health (Therapeutic Goods Administration)

alternating-pressure bed mattress overlay system

novis healthcare pty ltd - 47478 - alternating-pressure bed mattress overlay system - alternating air mattress system for the prevention and treatment of skin breakdown and pressure injuries in patients of high to very high risk. it is designed to replace your existing bed mattress on either a standard or profiling electric bed frame. the system is constructed from transverse air cells that cyclically inflate and deflate in an alternating pattern, providing gentle and dynamic support. cyclic alternation of pressure prevents arterial and venous capillary occlusion in the patient?s surface tissue ? maintaining and stimulating the flow of blood and lymphatic fluids through these tissues to provide essential oxygen

Specimen receptacle IVDs Australia - English - Department of Health (Therapeutic Goods Administration)

specimen receptacle ivds

avsec consulting pty limited - ct936 - specimen receptacle ivds - the teratube is a container intended to contain a specimen of air exhaled from a patient for subsequent in vitro determination of chemical and/or biological markers (e.g., volatile organic compounds) in the specimen to aid metabolic profiling or the diagnosis of disorders [for example, lipid peroxidation levels, gastrointestinal h. pylori infection, coronavirus disease (covid-19) infection]. it may include a port for blowing into the container, an access device (e.g., tubing) to facilitate specimen collection, and/or an adaptor for connection to an analyser. this is a single-use device.

ACLASTA SOLUTION Canada - English - Health Canada

aclasta solution

sandoz canada incorporated - zoledronic acid (zoledronic acid monohydrate) - solution - 5mg - zoledronic acid (zoledronic acid monohydrate) 5mg - bone resorption inhibitors